Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Capobianco

Showing results (21-30 of 22) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 22 results.
Lung Cancer (Amsterdam, Netherlands)|June 21, 2016
CIGB-300, an anti-CK2 peptide, inhibits angiogenesis, tumor cell invasion and metastasis in lung cancer modelsFernando Benavent Acero, Carla S Capobianco, Juan Garona, et al.
Translational Lung Cancer Research|October 24, 2025
Combination of racotumomab immunotherapy with programmed death-1 blockade in a preclinical model of non-small cell lung cancerValeria I Segatori, Selene Rojo, Cynthia A Gulino, et al.
Pageof 3

Showing results (21-30 of 22) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 22 results.
Lung Cancer (Amsterdam, Netherlands)|June 21, 2016
CIGB-300, an anti-CK2 peptide, inhibits angiogenesis, tumor cell invasion and metastasis in lung cancer modelsFernando Benavent Acero, Carla S Capobianco, Juan Garona, et al.
Translational Lung Cancer Research|October 24, 2025
Combination of racotumomab immunotherapy with programmed death-1 blockade in a preclinical model of non-small cell lung cancerValeria I Segatori, Selene Rojo, Cynthia A Gulino, et al.
Pageof 3